ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed
Brian Matthew Zeglis
Matched on ORCID iD 0000-0002-9091-744X; OpenAlex author ID A5084837942; NIH RePORTER profile ID 9762203. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 6
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper, 1 grant
Papers 4
- ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody. Last author DOI 10.1158/1078-0432.ccr-21-1798↗
- Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-18-1650↗
- Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses. First author DOI 10.2967/jnumed.115.163824↗
- Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. First author DOI 10.1073/pnas.1506542112↗
Grants 1
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jason Stuart Lewis · 4 shared papers, 1 shared grant, 2015–2022 · strength 1.01
- Grant Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer U01CA221046↗
- Paper ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody. DOI 10.1158/1078-0432.ccr-21-1798↗
- Paper Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1078-0432.ccr-18-1650↗
- Sai Kiran Sharma · 1 shared paper, 2022 · strength 0.13
- Michael Anthony Hollingsworth · 1 shared paper, 2022 · strength 0.13
- Prakash Radhakrishnan · 1 shared paper, 2022 · strength 0.13
- Jacob L. Houghton · 2 shared papers, 2015–2016 · strength 0.12
- Paper Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiati… DOI 10.2967/jnumed.115.163824↗
- Paper Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancre… DOI 10.1073/pnas.1506542112↗
- Sophie Poty · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.